The antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028.
Antibiotics are powerful medicines that are used to fight against bacterial infections and diseases. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). The antibiotics market do not work against any viral infection. Some of the common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat), and among others.
Lucrative Regional Antibiotics Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Development of Generic Drugs
A generic medicine is a copy of a branded drug that is no longer under patent. Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. For instance, according to a study published on the NCBI in 2018, the average brand name prescription price was almost 4-times the average generic price. Additionally, the companies are also focusing on the development of generic versions with an aim to offer antibiotics at minimal costs. For instance, in June 2018, Lupin launched generic Tobramycin inhalation solution in the US market. Further, encouragement from government authorities is also projected to drive the production of generic antibiotics, which would eventually drive the growth of the antibiotics market during the forecast period. For instance, in February 2019, the US Food and Drug Administration (US FDA) announced approval for commercialization of generic medicines manufactured by Indian drug companies in the US.
Test Type Insights
Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2020; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.
Global Antibiotics Market, by Product Type – 2020 & 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Action-Mechanism Insights
Based on action mechanism, the antibiotics market has been segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2020, whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Antibiotics Market: Strategic Insights
Market Size Value in US$ 44,111.31 Million in 2020 Market Size Value by US$ 59,253.24 Million by 2028 Growth rate CAGR of 4.0% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Antibiotics Market: Strategic Insights
| Market Size Value in | US$ 44,111.31 Million in 2020 |
| Market Size Value by | US$ 59,253.24 Million by 2028 |
| Growth rate | CAGR of 4.0% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approval strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide and meet the growing demand.
The market players operating in the antibiotics market adopt the strategy of expansion to enlarge customer base across the world, which also permits the players to maintain their brand name globally. For instance, in July 2019, the company such as Pfizer has launched an international research consortium to discover and develop new TB antibiotics in collaboration with eight biotechnology partners and European academic.
Global Antibiotics Market – By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
Global Antibiotics Market – By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Global Antibiotics – By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Pfizer, Inc
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
- Abbott,
- GlaxoSmithKline Plc,
- Sanofi,
- Novartis AG,
- Bayer AG,
- Bristol Myers Squibb Company,
- Eli Lilly and Company,
- Astellas Pharma
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Class ; Action Mechanism , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The North American region holds the largest market for the breast cancer screening. The United States held the largest market for antibiotics market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer , growing developments for screening and imaging process by the companies and others.
The growth of the market is attributed to some key driving factors such as rising prevalence of bacterial infections, growing geriatric population and increasing development of generic drugs. However, tedious and expensive process of antibiotic development is expected to restraint the growth of the market during the forecast years.
Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antibiotics Market – By Drug Class
1.3.2 Global Antibiotics Market – By Action Mechanism
1.3.3 Global Antibiotics Market – By Geography
2. Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antibiotics Market – Market Landscape
4.1 Pest Analysis
4.1.1 North America– PEST Analysis
4.1.2 Europe– PEST Analysis
4.1.3 Asia Pacific
4.1.4 Middle East & Africa
4.1.5 South & Central America
5. Antibiotics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Increasing Development of Generic Drugs
5.2 Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – Global Analysis
6.1 Global Antibiotics Market Revenue Forecast And Analysis
6.2 Global Antibiotics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Antibiotics Market Analysis – By Drug Class
7.1 Overview
7.2 Antibiotics Market Revenue Share, by Drug Class (2020 and 2028)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 Sulfonamides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 Aminoglycosides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Carbapenem
7.5.1 Overview
7.5.2 Carbapenem: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Macrolides
7.6.1 Overview
7.6.2 Macrolides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 Fluoroquinolones: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Penicillin
7.8.1 Overview
7.8.2 Penicillin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Cephalosporin
7.9.1 Overview
7.9.2 Cephalosporin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8. Antibiotics Market – By Action Mechanism
8.1 Overview
8.2 Antibiotics Market, by Action Mechanism, 2020 and 2028 (%)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 Mycolic Acid Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 RNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 DNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 Protein Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 Cell Wall Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9. Antibiotics Market – Geographic Analysis
9.1 North America: Antibiotics Market
9.1.1 Overview
9.1.2 North America: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.1.4 North America: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.1.5 North America: Antibiotics Market, by Country, 2020 & 2028 (%)
9.1.6 US: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 US: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 US: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.1.6.3 US: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.1.7 Canada: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Canada: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Canada: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.1.7.3 Canada: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.1.8 Mexico: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Mexico: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Mexico: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.1.8.3 Mexico: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.2 Europe: Antibiotics Market
9.2.1 Overview
9.2.2 Europe: Antibiotics Market - Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.2.4 Europe: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.2.5 Europe: Antibiotics Market, by Country, 2020 & 2028 (%)
9.2.6 Germany: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.1 Germany: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.2 Germany: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.2.6.3 Germany: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.2.7 UK: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.1 UK: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.2 UK: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.2.7.3 UK: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.2.8 France: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.1 France: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.2 France: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.2.8.3 France: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.2.9 Spain: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.1 Spain: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.2 Spain: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.2.9.3 Spain: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.2.10 Italy: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.10.1 Italy: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.2.10.2 Italy: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.2.10.3 Italy: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.3 Asia Pacific: Antibiotics Market
9.3.1 Overview
9.3.2 Asia Pacific: Antibiotics Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Asia Pacific: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.3.4 Asia Pacific: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.3.5 Asia Pacific: Antibiotics Market, by Country, 2020 & 2028 (%)
9.3.6 China: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.6.1 China: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.6.2 China: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.3.6.3 China: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.3.7 Japan: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.7.1 Japan: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.7.2 Japan: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.3.7.3 Japan: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.3.8 India: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.8.1 India: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.8.2 India: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.3.8.3 India: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.3.9 South Korea: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.9.1 South Korea: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.9.2 South Korea: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.3.9.3 South Korea: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.3.10 Australia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.10.1 Australia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.3.10.2 Australia: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.3.10.3 Australia: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.4 Middle East & Africa: Antibiotics Market
9.4.1 Overview
9.4.2 Middle East & Africa: Antibiotics Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Middle East & Africa: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.4.4 Middle East & Africa: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.4.5 Middle East & Africa: Antibiotics Market Share by Country – 2019 & 2027, (%)
9.4.6 Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.4.6.1 Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.4.6.2 Saudi Arabia: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.4.6.3 Saudi Arabia: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.4.7 UAE: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.4.7.1 UAE: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.4.7.2 UAE: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.4.7.3 UAE: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.4.8 South Africa: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.8.1 South Africa: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.4.8.2 South Africa: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.4.8.3 South Africa: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.5 South and Central America: Antibiotics Market
9.5.1 Overview
9.5.2 South and Central America: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.5.3 South and Central America: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.5.4 South and Central America: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.5.5 South and Central America: Antibiotics Market, by Country, 2020 & 2028 (%)
9.5.6 Brazil: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.1 Brazil: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.2 Brazil: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.5.6.3 Brazil: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
9.5.7 Argentina: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.5.7.1 Argentina: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
9.5.7.2 Argentina: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)
9.5.7.3 Argentina: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTICS MARKET
10.1 North America: Impact assessment of COVID-19 Pandemic
10.2 Europe: Impact assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
10.4 Rest of World: Impact assessment of COVID-19 Pandemic
11. Antibiotics Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Antibiotics Market, 2016-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sanofi
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bayer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bristol-Myers Squibb Company
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Astellas Pharma Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Abbott
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Eli Lilly and Company.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 3. US Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 4. US Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 9. Europe Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 10. Europe Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 11. Germany Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 12. Germany Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 13. UK Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 14. UK Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 15. France Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 16. France Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 17. Spain Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 19. Italy Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 20. Italy Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 21. Asia Pacific Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 22. Asia Pacific Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 23. China Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 24. China Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 25. Japan Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 26. Japan Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 27. India Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 28. India Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 29. South Korea Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 30. South Korea Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 31. Australia Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 32. Australia Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 33. Middle East & Africa Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 34. Middle East & Africa Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 35. Saudi Arabia Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 36. Saudi Arabia Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 37. UAE Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 38. UAE Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 39. South Africa Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 40. South Africa Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 41. South and Central America Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 42. South and Central America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 43. Brazil Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 44. Brazil Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 45. Argentina Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 46. Argentina Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)
Table 47. Recent Inorganic Growth Strategies in the antibiotics Market
Table 48. Recent Organic Growth Strategies In The Antibiotics Market
Table 49. Glossary of Terms, Antibiotics Market
LIST OF FIGURES
Figure 1. Antibiotics Market Segmentation
Figure 2. Antibiotics Segmentation, By Region
Figure 3. Global Antibiotics Market Overview
Figure 4. The Cephalosporin Segment Held Largest Share Of Drug Class Segment In Antibiotics Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Antibiotics Market, By Geography (US$ Million)
Figure 7. Global Antibiotics Market- Leading Country Markets (US$ Million)
Figure 8. Global Antibiotics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Antibiotics market impact analysis of driver and restraints
Figure 15. Global Antibiotics Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Antibiotics Market – By Geography Forecast And Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Antibiotics Market
Figure 18. Antibiotics Market Revenue Share, by Drug Class (2020 and 2028)
Figure 19. Sulfonamides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Aminoglycosides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Carbapenem: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Macrolides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Fluoroquinolones: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Penicillin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Cephalosporin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Antibiotics Market, by Action Mechanism, 2020 and 2028 (%)
Figure 28. Mycolic Acid Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. RNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. DNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Protein Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Cell Wall Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. North America Antibiotics Market Revenue and Forecast to 2028 (USD Million)
Figure 36. North America: Antibiotics Market, by Country, 2020 & 2028 (%)
Figure 37. US: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Canada: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Mexico: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Europe: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 41. Europe Antibiotics Market Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Antibiotics Market, by Country, 2020 & 2028 (%)
Figure 43. Germany: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. UK: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. France: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Spain: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Italy: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Asia Pacific: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 49. Asia Pacific Antibiotics Market Revenue and Forecast to 2028 (USD Million)
Figure 50. China: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Japan: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. India: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. South Korea: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Australia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Middle East & Africa: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 56. Middle East & Africa Antibiotics Market Revenue and Forecast to 2028 (USD Million)
Figure 57. Middle East & Africa: Antibiotics Market Share by Country – 2019 & 2027, (%)
Figure 58. Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. UAE: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. South Africa: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. South and Central America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. South and Central America Antibiotics Market Revenue and Forecast to 2028 (USD Million)
Figure 63. South and Central America: Antibiotics Market, by Country, 2020 & 2028 (%)
Figure 64. Brazil: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Argentina: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Impact Of Covid-19 Pandemic In North American Country Markets
Figure 67. Impact Of Covid-19 Pandemic In Europe Country Markets
Figure 68. Impact Of Covid-19 Pandemic In Asia-Pacific Country Markets
Figure 69. Impact Of Covid-19 Pandemic In Rest Of World Country Markets
Figure 70. Growth Strategies in The Antibiotics Market, 2016-2020
The List of Companies - Antibiotics Market
- Pfizer, Inc
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
- Abbott,
- GlaxoSmithKline Plc,
- Sanofi,
- Novartis AG,
- Bayer AG,
- Bristol Myers Squibb Company,
- Eli Lilly and Company,
- Astellas Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Antibiotics Market
Apr 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)